Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily of cytokines, is one of the most promising candidates for cancer therapeutics. However, many osteosarcomas are resistant to TRAIL. Bisphosphonates are very effective in the treatment of bone proble...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Moon, Myung-Hee, Jeong, Jae-Kyo, Seo, Jae-Suk, Seol, Jae-Won, Lee, You-Jin, Xue, Meilang, Jackson, Christopher J., Park, Sang-Youel
Formato: Artigo
Idioma:Inglês
Publicado: Korean Society for Biochemistry and Molecular Biology 2011
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068296/
https://ncbi.nlm.nih.gov/pubmed/21297379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3858/emm.2011.43.3.016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares